Calendar of Events & Lectures

Today
This Week

Monday, October 8, 2018

Transcription Factor Function in Pluripotent and Primordial Germ Cell States

| A-106 (ENTER THROUGH A-108) WCMC, 1300 YORK AVE.
Tri-Institutional Events (at MSK & WCM), Cell Biology Seminars
Ian Chambers, Ph.D., professor of pluripotent stem cell biology, University of Edinburgh

Memory B Cells and Infection

| 105 ZRC, MSKCC, 417 E. 68TH ST.
Tri-Institutional Events (at MSK & WCM), Other Tri-Institutional Events
Marion Pepper, Ph.D., associate professor, department of immunology, University of Washington

Synthetic Biology for Synthetic Chemistry

| 105 ZRC, MSKCC, 417 E. 68TH ST.
Tri-Institutional Events (at MSK & WCM), Other Tri-Institutional Events
Jay Keasling, Ph.D., professor, department of chemical and biomolecular engineering, professor, department of bioengineering, The Hubbard Howe Jr. Distinguished Professor of Biochemical Engineering, senior faculty scientist, Lawrence Berkeley National Laboratory, chief executive officer, Joint BioEnergy Institute (JBEI), University of California, Berkeley

Tri-Institutional Calendars

The close proximity among the three institutions which comprise the Tri-I has led to a culture that encourages interinstitutional interactions and shared resources, including access to lectures and seminars from internationally renowned scientists and clinicians:

Upcoming Events

Microscale Biophysics of the Ocean: A Single-Cell Perspective on the Biological Carbon Pump

| CARSON FAMILY AUDITORIUM (CRC)

Liquid Biopsies in Pediatric Solid Tumors

| CARSON FAMILY AUDITORIUM (CRC)

Spying on the Immune System

| CASPARY AUDITORIUM
The Philip Levine Memorial Lecture

News

Some mammals can hit pause on a pregnancy. Understanding how that happens could help us treat cancer.

New study reveals the molecular brake that lets embryonic stem cells enter suspended animation, while retaining the ability to develop normally—which could shed light on abnormal cell growth in humans.

New engineered derivative of a natural molecule could translate into a powerful replacement for IVIG therapy for a wide array of autoimmune disorders

In experiments with mice, the new molecule accomplished the same job at a hundredth of the dose.

This new insight into T cell receptors may improve cancer immunotherapies

Researchers discovered that a crucial first step in the signaling system operates differently than previously thought, an insight that could lead to the next generation of treatments.

Room Reservation Calendar